NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

I agree with this post. However due to emotional reactions of FOMO and short covering I see at least the possibility of a $20 to $35 million market cap based on M&A activity in Biotechs in the last few years. If no buyout or partnerships putting that higher floor in then if it substaintially holds through approval then the professional investors/institutions will assess the new risks of execution of business plan post approval. This might manifest in a price drop after approval and NWBO might be rated according to how well they are doing as a revenue Company together with potential expanded indications.
Many or a predominate number of Biotechs have the largest percentage increases in value prior to approval based on "Market appriecation" of potential.
A striking example of this was seen in Biogen Market cap rise when BIIB did an about face on the Alzheimer's drug and switched from shelving the program to reviving it. Now know as Aduhelm it faces huge execution risks.